These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23620108)

  • 1. Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
    Nakamori T; Kosuda S; Kyoto Y; Fujikawa A; Naoi Y; Nakamori Y
    Jpn J Radiol; 2013 Aug; 31(8):542-5. PubMed ID: 23620108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loco-regional staging of malignant pleural mesothelioma by integrated
    Murphy DJ; Mak SM; Mallia A; Jeljeli S; Stirling JJ; Goh V; Bille A; Cook GJR
    Eur J Radiol; 2019 Jun; 115():46-52. PubMed ID: 31084758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
    Brocken P; van der Heijden HF; Dekhuijzen PN; Peters-Bax L; de Geus-Oei LF
    Respiration; 2014; 87(1):32-7. PubMed ID: 23595051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
    Mahmood S; Martinez de Llano SR
    Clin Nucl Med; 2008 Jul; 33(7):510-2. PubMed ID: 18580246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹⁸F-FDG-PET/CT in malignant mesothelioma.
    Fuccio C; Spinapolice EG; Ferretti A; Castellucci P; Marzola MC; Trifirò G; Rubello D
    Biomed Pharmacother; 2013 Jul; 67(6):539-42. PubMed ID: 23583476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
    Niccoli-Asabella A; Notaristefano A; Rubini D; Altini C; Ferrari C; Merenda N; Fanelli M; Rubini G
    Clin Imaging; 2013; 37(6):1098-103. PubMed ID: 23932389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
    Huang YC; Tu DG; Wu JD; Lee MY
    Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural tuberculosis mimicking malignant pleural mesothelioma by
    Ai L; Wang W; Li Y
    Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842
    [No Abstract]   [Full Text] [Related]  

  • 13. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
    Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(18)F]-FDG PET and localized fibrous mesothelioma.
    Cortes J; Rodriguez J; Garcia-Velloso MJ; Rodriguez-Espiteri N; Boan JF; Castellano JM; Torre W
    Lung; 2003; 181(1):49-54. PubMed ID: 12879339
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
    Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.
    Ost P; Rottey S; Smeets P; Boterberg T; Stragier B; Goethals I
    J Thorac Imaging; 2008 Feb; 23(1):35-8. PubMed ID: 18347518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.
    Truong MT; Viswanathan C; Godoy MB; Carter BW; Marom EM
    Semin Roentgenol; 2013 Oct; 48(4):323-34. PubMed ID: 24034264
    [No Abstract]   [Full Text] [Related]  

  • 20. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
    Lee SM; Park CM; Paeng JC; Im HJ; Goo JM; Lee HJ; Kang CH; Kim YW; Kim JI
    Eur Radiol; 2012 Jul; 22(7):1556-63. PubMed ID: 22358427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.